Check care
What supports a treatment claim?
Request evidence for the particular medicine under discussion and its proposed use. A claim about one product does not answer a question about every injection.
What does an approval tell me?
When the Food and Drug Administration (FDA) approves a medicine, that approval applies to a particular product and stated uses.
As of September 26, 2026.
FDA · A product’s approved usesSemaglutide (Ozempic, Wegovy) has approved products with different forms and uses.
As of September 26, 2026.
FDA · Match the product and its useAsk whether the claim refers to the exact product being proposed, and whether it refers to people with the condition being assessed.
Does evidence for an approved drug cover a pharmacy-made copy?
According to FDA, it is false or misleading to claim proven equal results between pharmacy-made medicines and approved drugs.
As of September 26, 2026.
FDA · Claims that overreach the evidenceFDA has not reviewed the finished pharmacy-made medicine for its quality, safety, or treatment results.
As of September 26, 2026.
FDA · A separate finished productWhat if human safety information is thin?
FDA’s peptide ingredient concerns include limited human safety information, unwanted immune reactions, and difficulty identifying impurities.
As of September 26, 2026.
FDA · Gaps in peptide safety informationIn an immune reaction, the body can respond to a substance as though an invader has entered. Impurities are unwanted material mixed into the ingredient.
As of September 26, 2026.
FDA · The concerns in plain wordsAsk what is known, what remains uncertain, and how those gaps affect the proposed care.
Is a committee headline a change in the rules?
An FDA committee gives advice about which ingredients may go on a legal list for making pharmacy-made medicines. Its vote alone cannot add an ingredient to that list. FDA must go through a formal change to the rules, with a chance for the public to comment.
As of September 26, 2026.
FDA · Steps for changing the ingredient listThe July 2026 meeting concerned peptide ingredients for pharmacy-made medicines. As of September 26, 2026, FDA had published no official record of the committee’s votes. That means the votes could not be checked in that written record, not that no vote happened.
As of September 26, 2026.
FDA · Available meeting materialsAsk for the final official record behind a claim that the rules changed.